Dendritic cell-based immunotherapy: Began Phase I study

By WIR Staff | Feb 22, 2000 | 8:00 AM GMT

Northwest Biotherapeutics Inc., Seattle, Wash.
Product: Dendritic cell-based

Read the full 88 word article

How to gain access

Continue reading with a
two-week free trial.